Evidence map›Paper›PMID 37369225›Full record

ArticlePhysics in medicine and biology2023

Image-guided focused ultrasound-mediated molecular delivery to breast cancer in an animal model.

Ryan Margolis, Lokesh Basavarajappa, Junjie Li, Girgis Obaid, Kenneth Hoyt

Open access · hybridAbstract read
In one paragraph

Article in Physics in medicine and biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ryan MargolisDepartment of Bioengineering, University of Texas at Dallas, Richardson, TX, United States of America.
Lokesh BasavarajappaDepartment of Bioengineering, University of Texas at Dallas, Richardson, TX, United States of America.
Junjie LiDepartment of Bioengineering, University of Texas at Dallas, Richardson, TX, United States of America.
Girgis ObaidDepartment of Bioengineering, University of Texas at Dallas, Richardson, TX, United States of America.
Kenneth HoytDepartment of Bioengineering, University of Texas at Dallas, Richardson, TX, United States of America.ORCID 0000-0003-2379-8273
The University of Texas at Dallas · US

Funding

Multifrequency ultrasound imaging for improved breast tissue characterizationR01CA269973 · NCI · UNIVERSITY OF TEXAS DALLAS · PI HOYT, KENNETH · 2022 to 2025
$2.8M
3D Super-Resolution Ultrasound Imaging for Cancer Detection and Treatment MonitoringR01EB025841 · NIBIB · UNIVERSITY OF TEXAS DALLAS · PI HOYT, KENNETH · 2019 to 2022
$1.3M
NCI NIH HHS R01 CA269973NIBIB NIH HHS R01 EB025841
6 · The paper itself

Abstract

Tumors become inoperable due to their size or location, making neoadjuvant chemotherapy the primary treatment. However, target tissue accumulation of anticancer agents is limited by the physical barriers of the tumor microenvironment. Low-intensity focused ultrasound (FUS) in combination with microbubble (MB) contrast agents can increase microvascular permeability and improve drug delivery to the target tissue after systemic administration. The goal of this research was to investigate image-guided FUS-mediated molecular delivery in volume space. Three-dimensional (3-D) FUS therapy functionality was implemented on a programmable ultrasound scanner (Vantage 256, Verasonics Inc.) equipped with a linear array for image guidance and a 128-element therapy transducer (HIFUPlex-06, Sonic Concepts). FUS treatment was performed on breast cancer-bearing female mice (

Indexed as

Antineoplastic AgentsNeoplasmsAnimalsBlood-Brain BarrierContrast MediaDrug Delivery SystemsFemaleMiceMicrobubblesModels, AnimalTumor MicroenvironmentAntineoplastic AgentsContrast Mediacancerdrug deliveryfocused ultrasoundimage-guided therapymicrobubble contrast agentsoptical imaging

Identifiers

PMID37369225
PMCPMC10439523
OpenAlexW4382199310

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.